Abstract: Chronic kidney disease (CKD) is a serious condition associated with premature mortality, decreased quality of life, and increased health-care expenditures. A failure to produce sufficient Erythropoietin (EPO) accounts for the moderate to severe anemia observed in chronic kidney disease. Decreased EPO production is attributed to the destruction of renal production sites. A cross-sectional descriptive study was designed for the determination of erythropoietin levels in chronic kidney disease patients with anemia. At the same time measurement of serum iron and serum ferritin to establish anemia. The serum concentration of erythropoietin was the parameter taken to evaluate the kidney status. This study was carried out in the Nephrology ward, Chittagong Medical College Hospital (CMCH), Chittagong, Bangladesh during the period of January 2012 to December 2012. Total Sixty Patients having hemoglobin level < 11 gm/dl and serum creatinine > 3 mg/dl taken as a case of chronic kidney disease with anemia. Mean Hemoglobin level found 8.67gm/dl [± 1.39SD(standard deviation), Serum creatinine level found 8.21 mg/dl (±3.25 SD), Serum erythropoietin level found 2.67 Miu (mili international unit)/ml (± 2.36 SD), Serum iron level found 13.78 µg/dl (±2.58 SD). Serum ferritin level found 73.35ng/mL (± 26.81SD). It is also observed that Pearson’s correlation coefficient (r) between erythropoietin and hemoglobin is – 0.190 (r=0.036, p value=0.145), which is not significant. Correlation coefficient between erythropoietin and creatinine is – 0.082 (r=0.007 p-value = 0.532), which is not significant. The correlation coefficient between erythropoietin and iron is 0.021 (r=4.549, p-value =0.872), which is not significant but shows a weakly positive correlation. The correlation coefficient between erythropoietin and ferritin is 0.005 (r=2.723 p value=0.968) which is not significant but also shows weakly positive correlation. Further reading click here
Creatine kinase as a biomarker in muscle and heart health
1. **Creatine kinase (CK)** is an enzyme found in high concentrations in tissues with high energy demands—especially **skeletal muscle, heart muscle, and brain**—where it helps regenerate ATP from Creatine phosphate. 2. Because CK leaks into the blood when muscle cell membranes are damaged, its serum level serves as a general **marker of tissue injury** rather than damage to one specific organ. 3. CK exists as different **isoenzymes**—CK-MM (skeletal muscle), CK-MB (heart), and CK-BB (brain)—which help pinpoint the source of the damage. 4. **CK-MB** was long considered the classic biomarker for acute myocardial infarction, rising about 4–6 hours after injury, peaking near 24 hours, and returning to normal within 48–72 hours. 5. Its relatively **short half-life** makes CK-MB particularly valuable for detecting **re-infarction**, because levels fall quickly enough that a new rise is easy to recognize. 6. In skeletal muscle health, total CK is elevated in conditions such a...

0 Comments